Tenfold Growth for $5.2 Billion Cell and Gene Therapy Market from 2021-2031
“Oncology, cardiovascular-blood and genetic conditions will be key contributors to the cell and gene therapy market’s strong performance through 2031.” – Kalorama Information
It is an exciting and interesting time for companies involved in cell and gene therapy as the industry is forecast to grow tenfold between 2021 to 2031, according to leading medical market research firm Kalorama Information in Cell Therapy And Gene Therapy Markets, one of two new reports published on the topic.
Currently, the global cell and gene therapy market is worth an estimated $5,193 million ($5.2 billion) as of 2021. Kalorama Information anticipates sales from oncology, cardiovascular-blood and genetic conditions will be key contributors to the cell and gene therapy market’s strong performance going forward.
Cell and gene therapy offers promising treatments for many acquired diseases such as cancer, diabetes, Parkinson’s disease and genetic diseases to correct defective genetic material. The science is moving ahead and now the industry needs to industrialize and standardize the manufacturing and commercialization of products. The industry is moving in the direction of a standardized set-up and a closed automated system.
Consequently, cell and gene therapy products are transforming the treatment of cancers and genetic diseases. Additionally, cell and gene therapies are expanding into other areas of medicine including autoimmune diseases, cardiovascular diseases, musculoskeletal disease, dermatological diseases and many others.
For more insights and data from Cell Therapy And Gene Therapy Markets, purchase the report at: https://kaloramainformation.com/product/cell-gene-therapy-world-market/.
Also on sale is Kalorama Information’s companion report, Cell and Gene Therapy Deals: Financings, Partnering, M&A, Technology Transfers, IPOs, and Other Developments, which be purchased at: https://kaloramainformation.com/product/cell-and-gene-therapy-deals-analysis/.
In addition, Kalorama publishes a twice-monthly newsletter on this market, Cell and Gene Therapy Business Outlook. To subscribe visit: https://kaloramainformation.com/product/cell-and-gene-therapy-business-outlook/.
